Latest Breaking News On - Sutro biopharma daily - Page 2 : vimarsana.com

Sutro Biopharma (NASDAQ:STRO) Rating Reiterated by HC Wainwright

Sutro Biopharma (NASDAQ:STRO) Rating Reiterated by HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Los angelesUnited statesSutro biopharmaPiper sandlerBarclays plcPanagora asset management incLos angeles capital managementSutro biopharma incSg americas securitiesSutro biopharma company profileYork mellon corpFree reportBiopharma stock downGet free reportNew york mellon corpAsset management

Wedbush Reaffirms Outperform Rating for Sutro Biopharma (NASDAQ:STRO)

Wedbush Reaffirms Outperform Rating for Sutro Biopharma (NASDAQ:STRO)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Los angelesUnited statesPiper sandlerSutro biopharmaExchange traded conceptsSg americas securitiesSutro biopharma incNisa investment advisorsYork mellon corpLos angeles capital managementFree reportGet free reportNew york mellon corpInvestment advisorsTraded conceptsAngeles capital management

Sutro Biopharma, Inc (NASDAQ:STRO) Given Average Rating of Buy by Analysts

Sutro Biopharma, Inc (NASDAQ:STRO) Given Average Rating of Buy by Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Nicki vasquezPiper sandlerSutro biopharmaSutro biopharma incSecurities exchange commissionSectoral asset management incVontobel holding ltdOpaleye management incGet free reportMarketbeat ratingsBiopharma trading downExchange commissionCapital partnersCapital managementSectoral asset managementAsset management

Sutro Biopharma, Inc (NASDAQ:STRO) Receives $12 57 Average Price Target from Brokerages

Sutro Biopharma, Inc (NASDAQ:STRO) Receives $12 57 Average Price Target from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Nicki vasquezSutro biopharmaPiper sandlerVanguard group incExome asset managementBarclays plcNuveen asset managementVirtu financialSutro biopharma incSecurities exchange commissionGet free reportExchange commissionAsset managementBiopharma trading downGet freeSutro biopharma daily

Truist Financial Cuts Sutro Biopharma (NASDAQ:STRO) Price Target to $18 00

Truist Financial Cuts Sutro Biopharma (NASDAQ:STRO) Price Target to $18 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesSutro biopharmaNicki vasquezPrincipal financial group incAmerican century companies incPrudential financial incManufacturers life insurance companySutro biopharma incAmerican international group incFree reportTruist financialBiopharma stock downCentury companiesFinancial groupInternational groupPrudential financial